← Back to guidelines
Cardiology10 papers

Drug-induced hyperinsulinemia

Last edited: 4/10/2026

Overview

Drug-induced hyperinsulinemia is a condition where elevated insulin levels are caused by certain medications. This can lead to hypoglycemia and other metabolic disturbances.

Diagnosis

  • Diagnosis is typically made by identifying a temporal relationship between the initiation of a suspect medication and the onset of symptoms consistent with hyperinsulinemia, such as hypoglycemia.
  • Laboratory evaluation may include measurement of serum insulin, C-peptide, and glucose levels during a symptomatic episode.
  • Management

  • The primary management strategy involves discontinuing the offending medication 1.
  • If discontinuation is not possible or symptoms persist, symptomatic management of hypoglycemia may be required, including frequent carbohydrate intake and avoidance of fasting 1.
  • In some cases, pharmacologic agents to counteract hypoglycemia may be considered, though specific drug classes are not detailed in the provided abstracts.
  • Key Recommendations

  • Discontinue the causative medication if feasible 1.
  • Manage hypoglycemia with dietary modifications and avoidance of fasting if the medication cannot be stopped 1.
  • Consider symptomatic treatment for persistent hypoglycemia 1.
  • References

    1 Patel SB, Wyne KL, Afreen S, Belalcazar LM, Bird MD, Coles S et al.. American Association of Clinical Endocrinology Clinical Practice Guideline on Pharmacologic Management of Adults With Dyslipidemia. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2025. link

    Original source

    1. [1]
      American Association of Clinical Endocrinology Clinical Practice Guideline on Pharmacologic Management of Adults With Dyslipidemia.Patel SB, Wyne KL, Afreen S, Belalcazar LM, Bird MD, Coles S et al. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists (2025)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG